This aim has translational relevance because, at difference of CREBBP/EP300 causative gene mutations, the resulting epigenetic modifications are reversible and have been demonstrated to impact both brain development and adult brain function raising the opportunity of postnatal treatment with known and novel compounds to ameliorate the cognitive impairment of the patients [7, 49]. Here, EP300 is linked to Cognitive impairment.